Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

648
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
648
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

546
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
546

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.

Vaccine·2023
Same author

Open reduction internal fixation with bone grafting for scapular body nonunion: A case report.

Trauma case reports·2022
Same author

The development of a consensus statement for the prescription of powered wheelchair standing devices in Duchenne muscular dystrophy.

Disability and rehabilitation·2020
Same author

A summary of tuberculosis drug resistance in Canada, 2003-2013.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
Same author

A summary of tuberculosis in Canada, 2013.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
Same author

Tuberculosis in Canada: 2017.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
Same journal

Device and surgical procedure-related infections in Canadian acute care hospitals, 2020-2024.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Same journal

Laboratory diagnosis of pertussis: A survey on provincial public health laboratory methods.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Same journal

Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2020-2024.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Same journal

A descriptive analysis of multi-jurisdictional enteric illness messaging web analytics data, 2020-2022.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Same journal

Out-of-pocket costs for people with tuberculosis disease in Toronto, Canada: A web-based survey at two tuberculosis treatment centres, April 2023-April 2025.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Same journal

Summary of approach to inclusive language in vaccine guidance from the National Advisory Committee on Immunization (NACI).

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

637

Tuberculosis in Canada: 1924-2012.

V Gallant1, S Ogunnaike-Cooke1, M McGuire1

  • 1Public Health Agency of Canada, Ottawa, Ontario.

Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|May 18, 2018
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) incidence has declined in Canada since the 1940s. However, foreign-born individuals and Aboriginal populations experience disproportionately high TB rates, necessitating targeted public health interventions.

More Related Videos

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K
Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis
06:14

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Published on: September 26, 2025

687

Related Experiment Videos

Last Updated: Feb 10, 2026

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

637
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K
Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis
06:14

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Published on: September 26, 2025

687

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Surveillance

Background:

  • Tuberculosis (TB) remains a significant global public health concern.
  • Understanding TB patterns is crucial for effective control and prevention strategies.
  • TB has been a notifiable disease in Canada since 1924.

Purpose of the Study:

  • To analyze national TB surveillance data from two key systems.
  • To identify and highlight significant trends in TB incidence in recent years.
  • To provide an overview of the epidemiology of TB in Canada.

Main Methods:

  • Analysis of TB incidence trends from 1924 to 2012.
  • Descriptive analysis of data from the Canadian Tuberculosis Reporting System (CTBRS) and Canadian Tuberculosis Laboratory Surveillance System (CTBLSS) (2002-2012).
  • Focus on demographic and origin-based case characteristics.

Main Results:

  • Overall TB incidence and case numbers have decreased since the 1940s.
  • Males and individuals aged 25-34 represent the largest case proportions.
  • From 2002-2012, 66% of cases were foreign-born, with the highest burden in Canadian-born Aboriginals (5x national average).
  • Drug resistance rates in Canada are below international levels.

Conclusions:

  • Canada exhibits one of the world's lowest TB rates.
  • Foreign-born individuals and Aboriginal peoples are disproportionately affected by TB in Canada.
  • Surveillance systems (CTBRS, CTBLSS) are vital for targeted resource allocation and TB control.